Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
2020 · Nature Communications · 417 citations
https://doi.org/10.1038/s41467-020-16602-0
M
Michael J. James
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
195
Papers
10.7K
Citations
52
h-index
135
i10-index
Michael J. James is an academic researcher from University of Leicester. The author has contributed to research in topics: Fatty Acid Research and Health & Inflammatory mediators and NSAID effects & Eicosanoids and Hypertension Pharmacology. The author has an h-index of 52, co-authored 166 publications.
ORCID: 0000-0002-6823-8520Papers by this author
worksDietary n-3 fatty acids and therapy for rheumatoid arthritis
1997 · Seminars in Arthritis and Rheumatism · 235 citations
https://doi.org/10.1016/s0049-0172(97)80009-1
Dietary n-3 fatty acids and therapy for rheumatoid arthritis
1997 · Seminars in Arthritis and Rheumatism · 235 citations
https://doi.org/10.1016/s0049-0172(97)80009-1
Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
2013 · Journal of Biological Chemistry · 145 citations
https://doi.org/10.1074/jbc.m112.436006
Regulation of tumor necrosis factor-α and IL-1 β synthesis by thromboxane A2 in nonadherent human monocytes
1997 · The Journal of Immunology · 110 citations
https://doi.org/10.4049/jimmunol.158.1.351
Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase
1997 · The Journal of Immunology · 96 citations
https://doi.org/10.4049/jimmunol.158.10.4930
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat